WebApr 12, 2024 · Sarepta Therapeutics, Inc. has a 52 week low of $61.28 and a 52 week high of $159.84. The company has a 50-day moving average price of $133.14 and a 200 day moving average price of $123.18. Web"DeckTherapeutics is pioneering the new field of “acute omega-3 fatty acid therapeutics”. Emulsions of our proprietary semi-synthetic omega-3 compounds are administered …
D-MAC Industries: SAME DAY Steel Deck from 30 Locations
WebDeckTherapeutics: DeckTherapeutics coordinated the development of THDG3 - a novel, patent protected omega-3 diglyceride emulsion as a drug candidate for acute emergency treatment for stroke.Acute injection of omega-3 fatty acid compounds (in 6 rodent stroke models) is associated with marked neuroprotection and preservation of both short and … WebDECKTHERAPEUTICS, INC. is a Delaware Domestic Corporation filed on January 23, 2024. The company's filing status is listed as Active and its File Number is 7249791. The Registered Agent on file for this company is Corporation Service Company and is located at 251 Little Falls Drive, Wilmington, DE 19808. roseberry park adress
DECKTHERAPEUTICS, INC. in Wilmington, DE Company Info
Web2 days ago · Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Celularity Inc. (. CELU Quick Quote. CELU - Free Report) : This clinical-stage biotechnology company has seen the Zacks ... WebApr 12, 2024 · PBLA. Trades from $ 1. Panbela Therapeutics (. PBLA Quick Quote. PBLA - Free Report) , a clinical stage biopharmaceutical company, gained almost 37.5% in pre-market hours on Apr 12. This occurred ... Webstandard of treatment for stroke. DeckTherapeutics is currently developing THDG3 emulsion as a drug candidate for standard emergency treatment for stroke, a global unmet need, with phase 2a trials planned in 2024. TECHNOLOGY & INDICATIONS: THDG3 efficacy is based on multiple molecular mechanisms of action in roseberry park crisis team